Drugs / GSK2830929A
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01616459 | Jul 2012 → Apr 2013 | streptococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK2830929A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01616459 ↗ |
| Known as | 11Pn | “pneumococcal vaccine 2830929A (11-valent vaccine or 11Pn vaccine)” NCT01616459 ↗ |
| Known as | 2830929A | “pneumococcal vaccine 2830929A (11-valent vaccine or 11Pn vaccine)” NCT01616459 ↗ |